Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00378924 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cardiology Biobank Registry

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Eligibility criteria shortened, about 3 wordsv18 Show moreShow less

    See this version in full on ClinicalTrials.gov ↗

  2. Site contact updatedv17
  3. 2 versions Re-verified since May 1, 2023, no change to tracked fieldsv15-v16
  4. Study description expanded, about 369 wordsv14 Show moreShow less

    See this version in full on ClinicalTrials.gov ↗

  5. Re-verified, no change to tracked fieldsv13
Show 11 earlier versionsHide 11 earlier versions
  1. Primary completion date: Mar 2020 to Apr 2030 Completion date: Apr 2020 to Apr 2030v12 Show all 2 changesShow less
    • Completion date: Apr 2020 to Apr 2030
  2. Eligibility criteria expanded, about 84 wordsv11 Show moreShow less

    See this version in full on ClinicalTrials.gov ↗

  3. Re-verified, no change to tracked fieldsv10
  4. Site contact updatedv9
  5. 4 versions Re-verified since Dec 12, 2014, no change to tracked fieldsv5-v8
  6. Study Status, Outcome Measuresv4
  7. Re-verified, no change to tracked fieldsv3
  8. Primary completion date: Mar 2020 Completion date: Apr 2020 · Start date: Dec 2003 · Site contact updated · 2 morev2 Show all 6 changesShow less
    • Completion date: Apr 2020
    • Start date: Dec 2003
    • Site contact updated
    • Eligibility criteria shortened, about 3 words
    • Study title expanded, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Emory University
375 trials monitored
See 21 trials at risk
Heart Disease
2,136 trials monitored
See 109 trials at risk
In the present study, investigators intend to establish a large database of cardiovascular patients. More specifically, investigators will create a database of approximately 12,000 cardiac catheterization and heart failure patients from Emory University Hospital, the Emory Clinic, Emory University Hospital Midtown, Grady Memorial Hospital, Atlanta VA Medical Center, Organized/Planned Community Events in the Atlanta Metropolitan area, held at places of Worship, local Community Centers, shopping Malls, doctor's Offices and Health Clinics and any other miscellaneous locations, e.g. Parks, Leisure centers, Conference centers. Once the data has been collected, investigators will run a variety of statistical analyses to which will help us to learn more about the factors that cause various cardiovascular diseases such as coronary heart disease, angina, heart failure, hypertension, and stroke. The statistical analyses will also help us to understand how these diseases can be treated more effectively. By collecting a large amount of data on a large number of cardiovascular patients, investigators will be able to analyze, with a great deal of precision, those factors that influence the onset, course, and treatment of cardiovascular disease. The results of these precise analyses can then be used to help optimize clinical efforts to prevent and treat cardiovascular disease.
Trial Details
NCT Number NCT00378924
Lead Sponsor Emory University
Conditions Cardiovascular Disease
Enrollment 12,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov